These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 16210330

  • 1. Histone acetylation regulates the cell type specific CIITA promoters, MHC class II expression and antigen presentation in tumor cells.
    Chou SD, Khan AN, Magner WJ, Tomasi TB.
    Int Immunol; 2005 Nov; 17(11):1483-94. PubMed ID: 16210330
    [Abstract] [Full Text] [Related]

  • 2. HDAC2 deacetylates class II transactivator and suppresses its activity in macrophages and smooth muscle cells.
    Kong X, Fang M, Li P, Fang F, Xu Y.
    J Mol Cell Cardiol; 2009 Mar; 46(3):292-9. PubMed ID: 19041327
    [Abstract] [Full Text] [Related]

  • 3. Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation.
    Zika E, Greer SF, Zhu XS, Ting JP.
    Mol Cell Biol; 2003 May; 23(9):3091-102. PubMed ID: 12697811
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Class II transactivator (CIITA) promoter methylation does not correlate with silencing of CIITA transcription in trophoblasts.
    Holtz R, Choi JC, Petroff MG, Piskurich JF, Murphy SP.
    Biol Reprod; 2003 Sep; 69(3):915-24. PubMed ID: 12748124
    [Abstract] [Full Text] [Related]

  • 10. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene.
    Rohn W, Tang LP, Dong Y, Benveniste EN.
    J Immunol; 1999 Jan 15; 162(2):886-96. PubMed ID: 9916712
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. CIITA is silenced by epigenetic mechanisms that prevent the recruitment of transactivating factors in rhabdomyosarcoma cells.
    Londhe P, Zhu B, Abraham J, Keller C, Davie J.
    Int J Cancer; 2012 Aug 15; 131(4):E437-48. PubMed ID: 21989738
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Collagen and major histocompatibility class II expression in mesenchymal cells from CIITA hypomorphic mice.
    Xu Y, McDonald J, Perloff E, Butticè G, Schreiber BM, Smith BD.
    Mol Immunol; 2007 Mar 15; 44(7):1709-21. PubMed ID: 16982097
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Positive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (CIITA) type IV promoter.
    Chen H, Gilbert CA, Hudson JA, Bolick SC, Wright KL, Piskurich JF.
    Mol Immunol; 2007 Feb 15; 44(6):1461-70. PubMed ID: 16765445
    [Abstract] [Full Text] [Related]

  • 18. IFN-gamma regulation of the type IV class II transactivator promoter in astrocytes.
    Dong Y, Rohn WM, Benveniste EN.
    J Immunol; 1999 Apr 15; 162(8):4731-9. PubMed ID: 10202014
    [Abstract] [Full Text] [Related]

  • 19. RB and a novel E2F-1 binding protein in MHC class II deficient B-cell lines and normal IFN-gamma induction of the class IL transactivator CIITA in class II non-inducible RB-defective tumor lines.
    Tschickardt ME, Lu Y, Jacim M, Ussery GD, Steimle V, Mach B, Blanck G.
    Int J Cancer; 1995 Aug 09; 62(4):461-5. PubMed ID: 7635572
    [Abstract] [Full Text] [Related]

  • 20. HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA: acquisition of antigen processing and presentation capacity.
    Sartoris S, Valle MT, Barbaro AL, Tosi G, Cestari T, D'Agostino A, Megiovanni AM, Manca F, Accolla RS.
    J Immunol; 1998 Jul 15; 161(2):814-20. PubMed ID: 9670958
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.